Propylene oxide causes central-peripheral distal axonopathy in rats

  • A. Ohnishi
  • T. Yamamoto
  • Y. Murai
  • Y. Hayashida
  • H. Hori
  • T. Tanaka
Conference paper


In Wistar rats subjected daily to a 6-hour exposure of propylene oxide (PO) at a concentration of 1,500 ppm (5 times a week for 7 weeks), ataxia developed in the hindlegs. Myelinated fibers in the hindleg nerves and in the fasciculus gracilis showed axonal degeneration, sparing the nerve cell body of the first sacral dorsal root ganglion and myelinated fibers of the first sacral dorsal and ventral roots. These pathologic findings are compatible with central-peripheral distal axonopathy. This is apparently the first animal model of PO neuropathy to be verified histologically.


Ethylene Oxide Peroneal Nerve Sural Nerve Propylene Oxide Axonal Degeneration 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Cavanagh JB (1984) The problems of neurons with long axons. Lancet 1: 1284–1287PubMedCrossRefGoogle Scholar
  2. 2.
    Cho E-S, Jortner BS, Schaumburg HH, Spencer PS (1979) A single intravenous injection of doxorubicin (Adriamycin) induces sensory neuronopathy in rats. Neurotoxicology 1: 583–591Google Scholar
  3. 3.
    Dyck PJ (1975) Pathologic alterations of the peripheral nervous system of man. In: Dyck PJ, Thomas PK, Lambert EH (eds) Peripheral neuropathy. WB Saunders: Philadelphia, pp 296–336Google Scholar
  4. 4.
    Glaser ZR (1979) Ethylene oxide: toxicology review and field study results of hospital use. J Environ Pathol Toxicol 2: 173–208PubMedGoogle Scholar
  5. 5.
    Gross JA, Haas ML, Swift TR (1979) Ethylene oxide neurotoxicity: report of four cases and review of the literature. Neurology 29: 973–983CrossRefGoogle Scholar
  6. 6.
    Hori H, Tanaka I, Ohnishi A, Inoue N, Akiyama T (1986) A new generator for producing propylene oxide vapor in inhalation toxicity studies. J Univ Occup Environ Health 8: 169–179Google Scholar
  7. 7.
    Jacobsen KH, Hackley EB, Feinsilver L (1956) The toxicity of inhaled ethylene oxide and propylene oxide vapors. AMA Arch Ind Health 13: 237–244Google Scholar
  8. 8.
    Landrigan PJ, Meinhardt TJ, Gordon J, Lipscomb JA, Burg JR, Mazzuckelli LF, Lewis TR, Lemen RA (1984) Ethylene oxide: an overview of toxicological and epidemiological research. Am J Ind Med 6: 103–115PubMedCrossRefGoogle Scholar
  9. 9.
    National Institutes of Health (1985) Toxicology and carcinogenesis studies of propylene oxide in F 344/N rats and B6C3F mice (inhalation studies). National Toxicology Program, Technical Report Series, No 267Google Scholar
  10. 10.
    National Institute of Occupational Safety and Health (1985) NIOSH pocket guide to chemical hazards, DHHS Publication No (NIOSH) 85–114. U.S. Government Printing Office: Washington, DCGoogle Scholar
  11. 11.
    O’Donoghue JL (1985) Alkanes, alcohols, ketones, and ethylene oxide. V. Ethylene oxide. In: O’Donoghue JL (ed) Neurotoxicity of industrial and commercial chemicals. CRC Press: Florida, pp 86–87Google Scholar
  12. 12.
    Ohnishi A, Murai Y, Ikeda M, Kuroiwa Y (1978) Experimental methylmercury intoxication. Morphometric analysis of the nerve fiber of the sural nerve, lumbar spinal roots and Goll’s tract. Neurol Med (Tokyo) 9: 564–572Google Scholar
  13. 13.
    Ohnishi A, Ikeda M (1980) Morphometric evaluation of primary sensory neurons in experimental p-bromophenylacetylurea intoxication. Acta Neuropathol (Berl) 52: 111–118CrossRefGoogle Scholar
  14. 14.
    Ohnishi A, Inoue N, Yamamoto T, Murai Y, Hori H, Koga M, Tanaka I, Akiyama T (1985) Ethylene oxide induces central-peripheral distal axonal degeneration of the lumbar primary sensory neurons in rats. Br J Ind Med 42: 373–379PubMedGoogle Scholar
  15. 15.
    Ohnishi A, Inoue N, Yamamoto T, Murai Y, Hori H, Tanaka I, Koga M, Akiyama T (1986) Ethylene oxide neuropathy in rats. Exposure to 250 ppm. J Neurol Sci 74: 215–221PubMedCrossRefGoogle Scholar
  16. 16.
    Sharma AK, Duguid IGM, Blanchard DS, Thomas PK (1985) The effect of insulin treatment on myelinated nerve fibre maturation and integrity and on body growth in streptozotocin-diabetic rats. J Neurol Sci 67: 285–297PubMedCrossRefGoogle Scholar
  17. 17.
    Spencer PS, Schaumburg HH (1976) Central-peripheral distal axonopathy. The pathology of dying back polyneuropathies. In: Zimmerman HM (ed) Progress in neuropathology. Grune and Stratton: New York, pp 253–295Google Scholar
  18. 18.
    Spencer PS, Schaumburg HH (1977) Ultrastructural studies of the dying-back process: IV. Differential vulnerabilities of PNS and CNS fibers in experimental central-peripheral distal axonopathies. J Neuropathol Exp Neurol 36: 300–320PubMedCrossRefGoogle Scholar
  19. 19.
    Sprinz H, Matzke H, Carter J (1982) Neuropathological evaluation of monkeys exposed to ethylene and propylene oxide, NTIS, PB83-134817, 1–9. U.S. Department of CommerceGoogle Scholar
  20. 20.
    Rowe VK, Hollingsworth RL, Oyen R, McColliser DD, Spencer HC (1956) Toxicity of propylene oxide determined on experimental animals. AMA Arch Ind Health 13: 228–236PubMedGoogle Scholar

Copyright information

© Springer-Verlag Wien 1995

Authors and Affiliations

  • A. Ohnishi
    • 1
  • T. Yamamoto
    • 1
  • Y. Murai
    • 1
  • Y. Hayashida
    • 2
  • H. Hori
    • 3
  • T. Tanaka
    • 3
  1. 1.Department of Neurology, Institute of Industrial Ecological SciencesUniversity of Occupational and Environmental HealthKitakyushuJapan
  2. 2.Department of Systems Physiology, Institute of Industrial Ecological SciencesUniversity of Occupational and Environmental HealthKitakyushuJapan
  3. 3.Department of Environmental Health Engineering, Institute of Industrial Ecological SciencesUniversity of Occupational and Environmental HealthKitakyushuJapan

Personalised recommendations